Health Care & Life Sciences » Biotechnology | Avax Technologies Inc.

Avax Technologies Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2003
2004
2005
2006
2007
Cash & Short Term Investments
1,388.70
1,560.80
5,573.20
1,484.60
5,903.20
Total Accounts Receivable
52.50
258.90
159.10
271.10
214.30
Inventories
48.80
13.60
12.70
10.50
11.50
Other Current Assets
270.60
204.20
243.50
210.30
317.10
Total Current Assets
1,760.60
2,037.50
5,988.50
1,976.50
6,446.10
Net Property, Plant & Equipment
1,325.80
1,176.10
1,090.10
879.20
742.70
Long-Term Note Receivable
345.80
240.40
81.50
0.40
0.40
Intangible Assets
188.40
188.40
188.40
188.40
188.40
Total Assets
3,620.60
3,642.40
7,348.50
3,044.60
7,377.60
ST Debt & Current Portion LT Debt
1,183.00
374.40
324.90
362.10
400.70
Accounts Payable
1,699.40
1,621.80
1,283.20
1,460.60
2,091.70
Income Tax Payable
-
205.70
120.90
-
-
Other Current Liabilities
-
224.50
91.90
877.60
1,501.40
Total Current Liabilities
2,882.40
2,426.40
1,820.80
2,700.30
3,993.70
Total Liabilities
2,882.40
2,426.40
1,820.80
2,700.30
3,993.70
Common Equity (Total)
2,936.80
2,459.00
1,852.60
3,330.80
286.20
Total Shareholders' Equity
738.20
1,216.00
5,527.60
344.20
3,383.80
Total Equity
738.20
1,216.00
5,527.60
344.20
3,383.80
Liabilities & Shareholders' Equity
3,620.60
3,642.40
7,348.50
3,044.60
7,377.60
Preferred Stock (Carrying Value)
3,675.00
3,675.00
3,675.00
3,675.00
3,670.00

About Avax Technologies

View Profile
Address
2000 Hamilton Street
Philadelphia Pennsylvania 19130
United States
Employees -
Website http://www.avax-tech.com
Updated 07/08/2019
AVAX Technologies, Inc. operates as bio-technology company, which engages in the provision of development and commercialization of vaccine therapies and technologies for the treatment of cancer. It offers biological manufacturing services to biotechnology and pharmaceutical companies. The company was founded by Kenneth E.